Methotrexate With or Without Cyclophosphamide in Treating Patients With Lymphocytic Leukemia
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Thomas P. Loughran, MD
Milton S. Hershey Medical Center
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
68 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Aurora Presbyterian Hospital
Aurora, Colorado, United States
- Boulder Community Hospital
Boulder, Colorado, United States
- Penrose Cancer Center at Penrose Hospital
Colorado Springs, Colorado, United States
- Ccop - Colorado Cancer Research Program
Denver, Colorado, United States
- Porter Adventist Hospital
Denver, Colorado, United States
- Presbyterian - St. Luke'S Medical Center
Denver, Colorado, United States
- Rose Medical Center
Denver, Colorado, United States
- St. Anthony Central Hospital
Denver, Colorado, United States
- St. Joseph Hospital
Denver, Colorado, United States
- Swedish Medical Center
Englewood, Colorado, United States
- St. Mary'S Regional Cancer Center at St. Mary'S Hospital and Medical Center
Grand Junction, Colorado, United States
- North Colorado Medical Center
Greeley, Colorado, United States
- Sky Ridge Medical Center
Lone Tree, Colorado, United States
- Hope Cancer Care Center at Longmont United Hospital
Longmont, Colorado, United States
- Mckee Medical Center
Loveland, Colorado, United States
- St. Mary - Corwin Regional Medical Center
Pueblo, Colorado, United States
- North Suburban Medical Center
Thornton, Colorado, United States
- Exempla Lutheran Medical Center
Wheat Ridge, Colorado, United States
- Medical Center of Central Georgia
Macon, Georgia, United States
- Rush-Copley Cancer Care Center
Aurora, Illinois, United States
- Robert H. Lurie Comprehensive Cancer Center at Northwestern University
Chicago, Illinois, United States
- Evanston Northwestern Healthcare - Evanston Hospital
Evanston, Illinois, United States
- Joliet Oncology-Hematology Associates, Limited - West
Joliet, Illinois, United States
- North Shore Oncology and Hematology Associates, Limited - Libertyville
Libertyville, Illinois, United States
- Ccop - Carle Cancer Center
Urbana, Illinois, United States
- Carle Cancer Center at Carle Foundation Hospital
Urbana, Illinois, United States
- Methodist Cancer Center at Methodist Hospital
Indianapolis, Indiana, United States
- Saint Anthony Memorial Health Centers
Michigan City, Indiana, United States
- Mcfarland Clinic, Pc
Ames, Iowa, United States
- Mercy Cancer Center at Mercy Medical Center - North Iowa
Mason City, Iowa, United States
- Mercy Medical Center - Sioux City
Sioux City, Iowa, United States
- Siouxland Hematology-Oncology Associates, Llp
Sioux City, Iowa, United States
- St. Luke'S Regional Medical Center
Sioux City, Iowa, United States
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Baltimore, Maryland, United States
- Borgess Medical Center
Kalamazoo, Michigan, United States
- Bronson Methodist Hospital
Kalamazoo, Michigan, United States
- West Michigan Cancer Center
Kalamazoo, Michigan, United States
- Fairview Ridges Hospital
Burnsville, Minnesota, United States
- Mercy and Unity Cancer Center at Mercy Hospital
Coon Rapids, Minnesota, United States
- Fairview Southdale Hospital
Edina, Minnesota, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 15 Sept 1999
- Primary completion
- 1 Dec 2010
- Completion
- 31 Mar 2012
- Last update posted
- 5 Jul 2023
- Registered enrollment
- 59
- Registry id
- NCT00003910
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 4 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.